Previous 10 | Next 10 |
Thorne HealthTech to Participate in Evercore ISI HEALTHCONx Conference PR Newswire NEW YORK , Nov. 16, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or "the Company") (NASDAQ: THRN), a leader in developing personalized, innovative solu...
Thorne HealthTech, Inc. (THRN) Q3 2022 Earnings Conference Call November 10, 2022 08:00 AM ET Company Participants Thomas Wilson - Vice President, Investor Relations Paul Jacobson - Chief Executive Officer Bryan Conley - Chief Financial Officer Michelle Crow ...
The following slide deck was published by Thorne HealthTech, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Thorne HealthTech, Inc. 2022 Q3 - Results - Earnings Call Presentation
Thorne HealthTech press release ( NASDAQ: THRN ): Q3 Non-GAAP EPS of $0.12 misses by $0.02 . Revenue of $58.4M (+21.7% Y/Y) misses by $5.04M . For further details see: Thorne HealthTech Non-GAAP EPS of $0.12 misses by $0.02, revenue of $58.4M misses by $5...
Thorne HealthTech Reports Third Quarter 2022 Results PR Newswire Updates Full-Year 2022 Guidance NEW YORK , Nov. 9, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: THRN), a leader in developin...
THORNE HEALTHTECH AND GENTEGRA COLLABORATE TO DEVELOP A NEXT-GENERATION WHOLE BLOOD DNA COLLECTION AND EXTRACTION KIT PR Newswire NEW YORK , Oct. 25, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader i...
Thorne HealthTech Announces Third Quarter 2022 Earnings Release Date and Conference Call PR Newswire NEW YORK , Oct. 18, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN ), a leader in developing innovative solutions for a personalized a...
THORNE AND TEAM LIQUID ANNOUNCE PARTNERSHIP BRINGING INNOVATIVE HEALTH AND WELLNESS SOLUTIONS TO THE ESPORTS COMMUNITY PR Newswire Multi-year collaboration to introduce top athletes and casual gamers alike to science-driven products that support enhanced performance an...
Summary Thorne HealthTech went public in September 2021, raising approximately $70 million in a U.S. IPO. The company designs and sells wellness and nutraceutical products worldwide. THRN has produced revenue growth but faces inflationary pressures, the loss of a significant d...
Thorne HealthTech ( NASDAQ: THRN ) said its blood collection device OneDraw was certified in Japan as a medical device after being cleared by the Pharmaceutical and Medical Devices Agency (PMDA). "We appreciate the help from our partners in Japan because we believ...
News, Short Squeeze, Breakout and More Instantly...
Thorne Healthtech Inc. Company Name:
THRN Stock Symbol:
NASDAQ Market:
Thorne Healthtech Inc. Website:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Thorne Healthtech Inc. (THRN) is expected to report for Q3 2023
L Catterton Completes Acquisition of Thorne HealthTech, Inc. PR Newswire NEW YORK , Oct. 16, 2023 /PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne ...